SCM
ZEAL

Soleus Capital Management’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History

Soleus Capital Management’s Portfolio ZEAL Stock Details ZEAL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-26,882
Closed -$892K – 62
2019
Q4 		$892K Buy
+26,882
New +$803K 0.86% 31

Other funds holding ZEAL

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.31B AUM 20.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return

Soleus Capital Management's ZEAL Position: Q1 2020 in Review

Soleus Capital Management sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q1 2020, closing a stake of 26,882 shares — an estimated $892K sold.

Soleus Capital Management first reported a position in ZEAL in Q4 2019 and held it in 1 quarter. The position peaked at $892K in Q4 2019. 19 funds tracked by Wall St. Rank hold ZEAL as of Q1 2020.

  • Soleus Capital Management reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q1 2020 after selling out during the quarter.
  • Soleus Capital Management sold 26,882 Zealand Pharma A/S American Depositary Shares shares in Q1 2020, an estimated $892K.
  • Soleus Capital Management first reported a position in Zealand Pharma A/S American Depositary Shares in Q4 2019 and held it in 1 quarter.
  • Soleus Capital Management's Zealand Pharma A/S American Depositary Shares position peaked at $892K in Q4 2019.
  • 19 funds tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q1 2020.

Based on Soleus Capital Management's 13F filing for Q1 2020, filed 15 May 2020.